March is a big month for marijuana in Illinois.
Aside from choosing between candidates vying for gubernatorial and attorney general nominations — all of whom have weighed in on the legalization debate — millions of voters in the state’s most populous county will be asked to decide for themselves whether Illinois should end cannabis prohibition.
Plus, legislation to give all of the state’s voters a chance to cast an up-or-down ballot on marijuana legalization later this year will be weighed by lawmakers at the Capitol in Springfield.
The current cannabis ballot question in Cook County is nonbinding. But because the county contains Chicago — and nearly half of the state’s total population — a strong “yes” vote on March 20 would give a huge boost to efforts to legalize marijuana that are currently being considered by state legislators.
The question reads:
“Shall the State of Illinois legalize the cultivation, manufacture, distribution, testing, and sale of marijuana and marijuana products for recreational use by adults 21 and older subject to state regulation, taxation and local ordinance?”
And last week, the state Senate Executive Committee approved a measure to place a similar cannabis legalization advisory question on the state’s November general election ballot. That question would read:
“Do you support the legalization of possession and use of marijuana by persons who are at least 21 years of age, subject to regulation and taxation that is similar to the regulation and taxation of tobacco and alcohol?”
The full Senate is scheduled to consider the measure on Tuesday. If it is approved there it will go before the House in the coming weeks.
Meanwhile, candidates for governor and attorney general have repeatedly addressed cannabis policy issues, with some making legalization a centerpiece of their campaigns.
Primary elections to pick the Democratic and Republican nominees for those offices will also be held on March 20.
See below to learn how the candidates responded to a marijuana legalization question included in a new survey conducted by the State Journal-Register newspaper in Springfield, Illinois.
(Marijuana Moment has also embedded relevant tweets from some candidates.)
Daniel Biss (D)
“I support the full legalization of marijuana, including for recreational use. I voted to decriminalize marijuana in 2016 and am co-sponsoring legislation to legalize marijuana. I believe that existing marijuana policies unfairly target communities of color, tear apart Illinois families, and unnecessarily burden taxpayers with the costs of prosecuting low-level offenses. By legalizing and taxing marijuana and by exercising my commutation powers, we can keep families together and raise revenue to invest in our communities.”
We need to legalize, not criminalize cannabis. It's time for us to radically reform our justice system so that it works for the rest of us. pic.twitter.com/99b7UO1pUC
— Daniel Biss (@DanielBiss) February 4, 2018
Marijuana policy is fundamentally a question of justice. As governor, I’ll fight for legalization. pic.twitter.com/58c3uAFmhQ
— Daniel Biss (@DanielBiss) January 22, 2018
— Daniel Biss (@DanielBiss) February 25, 2018
Hey Jeff Sessions, stop trying to drag us back into the 1980's—the War on Drugs was a failed and backwards policy. It's time to stop clinging to antiquated thinking and allow states to legalize marijuana: https://t.co/CbvdNrTUVr
— Daniel Biss (@DanielBiss) January 4, 2018
Bob Daiber (D)
“I’m for it, with two caveats: I would sign legislation only if the public approves, via an advisory referendum. This most not be done for the purpose of bringing in tax revenue – otherwise the tax rate will be set so high that you risk re-creating the very black market we’re trying to eliminate, and you put the state in the position of promoting marijuana use.
“There will be tax revenue, but it is incidental to the policy itself. But prohibition has proven to be more harmful than marijuana itself, and we have people sitting in jail for non-violent drug offenses. I would commute sentences and expunge the records of those who are guilty of marijuana offenses alone.”
Fully support legalization. This is a business that has a lot of potential development. It must be a referendum voted on by the people to legalize recreational marijuana.
— Bob Daiber (@BobDaiber) February 19, 2018
Today I present to you my regulatory structure for marijuana sales in the state of Illinois. As governor of IL, I will sign legislation if the public votes in support of legalization. You deserve to know what the legal marijuana industry would look like. #ilgov #marijuana #twill pic.twitter.com/lbVvzwHUBo
— Bob Daiber (@BobDaiber) February 20, 2018
Jeanne Ives (R)
“I oppose it. Even if the revenue increase was enough to solve our budget problems – which it is not – legalizing marijuana is the wrong way to solve our budget problems. The Colorado Impact Study on the effect of legalizing marijuana found: Marijuana‐related traffic deaths increased 48 percent in the three‐year average (2013‐2015) since Colorado legalized recreational marijuana compared to the three‐year average (2010‐2012) prior to legalization. During the same time, all traffic deaths increased 11 percent. Marijuana‐related traffic deaths increased 62 percent from 71 to 115 persons after recreational marijuana was legalized in 2013. Youth past month marijuana use increased 20 percent in the two year average (2013/2014) since Colorado legalized recreational marijuana compared to the two‐year average prior to legalization (2011/2012). Nationally youth past month marijuana use declined 4 percent during the same time. Colorado college age past month marijuana use for 2013/2014 was 62 percent higher than the national average. Illinois needs real, structural reform, not quick fixes.”
“I support the legalization of marijuana but only after we have done a thorough and comprehensive review through the University of Illinois to ensure that public safety and public health are put before profit from marijuana industry. We shouldn’t let the lobbyists write the laws for legalization, it should be done with public health and safety in mind.”
Joseph, we will build a cannabis system that ensures medical availability, reduces unneeded incarceration and creates a safe marketplace for all. Thank you for your support. https://t.co/Rjx2uQMUiA
— Chris Kennedy (@KennedyforIL) February 26, 2018
“To decrease the crime rate in this state, we need to decriminalize marijuana and end the ‘War on Drugs’ and this is discussed below… I believe that marijuana should be legalized throughout the entire state, similar to the situation in Colorado, California, etc. This would generate tens of thousands of new jobs and billions of dollars in extra revenue for the State of Illinois. This new revenue should be distributed directly to property owners as a direct rebate. In this way we could relieve the high property levels in this state.”
J.B. Pritzker (D)
“I also support legalizing and taxing recreational use of marijuana, which is estimated to generate as much as $700 million a year for the state… No more studies are needed to show it’s time for Illinois to safely move forward and legalize marijuana. As governor, I will modernize drug laws and move Illinois towards a criminal justice system that gives all Illinoisans a chance to reach their full potential. Importantly, it’s time to regulate and tax marijuana to generate much needed revenue for this state. This is not a moment for a governor like Rauner who stands with Trump. Illinois needs a governor who is ready to legalize marijuana in Illinois to help reform our criminal justice system, improve consumer safety, and increase state revenue. There is an abundance of evidence that shows we can do it in Illinois in a safe way and that it will have real benefits to our state.
“Criminalizing marijuana hasn’t made our communities safer, but has disproportionately impacted black and brown communities. The criminalization of cannabis never has been and never will be enforced fairly, and it’s time to bring that to an end. To right past wrongs, we also have to commute sentences of people in prison who are there for marijuana offenses.”
Our state should legalize marijuana. This is not a moment for a governor who stands with Donald Trump. pic.twitter.com/HTHObxJU5V
— JB Pritzker (@JBPritzker) January 12, 2018
As governor, I will stand up to Donald Trump’s attacks on Illinois communities, legalize marijuana, and modernize sentencing guidelines to create a criminal justice system that gives all Illinoisans a chance to reach their full potential.
— JB Pritzker (@JBPritzker) January 4, 2018
Bruce Rauner (R) — Incumbent
“I do not support the legalization of recreational marijuana. There are too many unknowns – let’s let other states conduct this particular experiment so we can fully understand the consequences before we make this decision in Illinois.”
ATTORNEY GENERAL CANDIDATES:
Scott Drury (D)
“I firmly believe Illinois will legalize marijuana in the near future, and I support that effort. It is important for Illinois to act responsibly in its move towards legalization. The licensing process must be open and transparent to prevent insiders, cronies, and organized crime syndicates from gaming the system. Further, there must be a concerted effort to protect and educate our children. As a parent, I see the impact legalization is having on the mindset of children – that is, they believe it has no harmful consequences. Additionally, as Attorney General, I will advocate for the federal government to allow banks to accept deposits from marijuana dispensaries and growers. Public safety is threatened when people can only conduct business in cash.”
Sharon Fairley (D)
“I support the legalization of marijuana so long as we are careful about regulating its use and distribution so as to ensure public safety. As attorney general, I would provide guidance to the legislature and law enforcement based on the best practices established by the handful of states that have already fully legalized marijuana.”
Aaron Goldstein (D)
“I believe marijuana should be legalized. One doesn’t have to be a user of marijuana to understand that the war on drugs—and the criminalization of marijuana in particular—has been an abysmal failure. Far too many of our citizens have been convicted and imprisoned for using marijuana, although little evidence exists to support our draconian drug laws. Ironically, rather than helping our citizens, criminalization of marijuana has encouraged the development of a huge and chaotic black market, with its inevitable consequences of gang violence and harm to many innocent bystanders.
“For these reasons, and based on the experience of other states that have legalized marijuana, I believe it is time to legalize marijuana in Illinois as well. It should be regulated—based on clear scientific evidence—to ensure that legal pot does not create any significant health or public safety risks to the people of Illinois and that the marijuana industry is run fairly and lawfully. As Attorney General, I will consult with attorneys general from states that have legalized marijuana to ensure that Illinois adopts best practices in the production, distribution and sales of marijuana, and that any tax revenue Illinois derives from the sale of marijuana is used for purposes that benefit all the people, not just the few who are politically connected.”
Gary Grasso (R)
“I have taken a strong stance on the opioid addiction issue. I could not in good conscience condone the legalization of marijuana and I would use the power of the Office of Attorney General to advocate against legalization of recreational marijuana. Marijuana is a gateway drug. It seems pretty clear to me that legalization of marijuana would lead to more problems associated with drug abuse.”
Erika Harold (R)
“Relevant stakeholders should begin the process of methodically analyzing and negotiating appropriate safeguards and regulatory frameworks for the legalization of marijuana for adult use in Illinois. This process should be approached with particular attention paid to protecting minors, providing sufficient mental health and substance abuse services, existing federal law and directives, and providing for proper testing protocol and equipment in marijuana-related automobile accidents. If approached in a thoughtful and deliberate manner, legalization should enable law enforcement officials to redirect their time and resources towards addressing more critical issues (such as the opioid epidemic), expand Illinois’ tax base, and decrease the number of people serving sentences for non-violent, marijuana-related offenses.”
Renato Mariotti (D)
“Our prisons are operating at 134 percent capacity, and there are nearly 43,000 individuals behind bars. Illinois will spend over $1.4 billion in the 2017 fiscal year incarcerating its citizens. Imprisoning non-violent marijuana users is not only morally misguided but a tremendous waste of resources. I support the legalization, regulation and taxation of marijuana, with one important caveat. We need strict safeguards in place to prevent this from becoming another insider industry in Illinois where the privileged and politically connected succeed to the detriment of working people and small businesses.”
Pat Quinn (D)
“I support legalization of recreational marijuana so long as strict requirements are put in place to regulate its production, distribution and retail sale in order to ensure that health and safety are protected, avoid corruption, and ensure that applicable taxes are paid. When I was Governor, I signed the bill to legalize medical marijuana.”
Kwame Raoul (D)
“Illinois has moved in the direction of legalization by way of supporting the use of medical marijuana and expanding upon that to cover more ailments. We have also moved to decriminalize possession of small amounts for personal use. The logical extension of these policies is to move toward legalization in a manner that appropriately regulates manufacture and distribution while taxing it capture the new economic activity that would accompany recreational use.”
Nancy Rotering (D)
“The benefits of legalizing recreational marijuana outweigh the negatives. Legalizing recreational marijuana would significantly reduce prison crowding and lower the cost of law enforcement. Over 80% of drug-related arrests nationwide between 2001 and 2010 involved amounts for personal use only. Like alcohol, recreational marijuana should be regulated. It should not be sold to people under 21, its production should be regulated to ensure quality and diminish risks, and technology needs to be developed to assess drivers’ capacity and use, similar to breathalyzer tests for field use purposes.
“Illinois, along with 28 other states, passed legislation creating a medical cannabis program permitting patients with debilitating medical conditions to register with the state in order to access marijuana for medical use. As Illinois’ Attorney General, I would defend the state against any federal intrusion, and work to ensure that patients with medical conditions – including people with cancer, those who live with seizures, or veterans with Post-Traumatic Stress Disorder – can continue to access the care they need. I would also pursue the feasibility of banks handling payments and related finances to ease the ability of patients to pay for their medication.”
Jesse Ruiz (D)
“I fully support legalization of recreational adult use in Illinois. As Attorney General, I will take every action available under law to protect Illinois’ right to make its own decisions about the legality of marijuana. I deplore U.S. Attorney General Jeff Sessions’ recent shortsighted decision to revoke the Obama Administration’s guidance on deferring to the states on marijuana enforcement. By rescinding the directive and offering nothing to take its place, Sessions has simply created chaos. I am especially concerned by the impacts of his actions on medical marijuana. The states have made it clear that legalized medical marijuana is supported by the vast majority of Americans. Especially as our nation confronts the horrifying opioid epidemic, it is critically important to find safe, effective alternatives for pain relief. Quite frankly, I cannot understand why Sessions would take an action that has triggered so much uncertainty throughout the industry and brought anxiety to patients who have come to rely on safe medical-grade cannabis products.
“If the General Assembly legalizes adult recreational use of marijuana in Illinois, I will work closely with the Legislature to develop a procedure to expunge the records of Illinoisans who have cannabis convictions on their records. I believe that California’s Prop. 64 offers a useful roadmap for petitioning to have their prior convictions reclassified or dismissed. Once a new law has been passed, I will hold a summit of county state’s attorneys and public defenders to begin the petition process for people who are being held by the Illinois Department of Corrections for marijuana-related crimes. Once an adult use bill is passed, Illinois should not be spending millions of dollars to incarcerate people for a crime that no longer exists.”
Photo courtesy of Democracy Chronicles.
Feds Send Warning Letter To Another CBD Company Over Medical Claims
The Food and Drug Administration (FDA) and Federal Trade Commission (FTC) sent a warning letter to a Florida-based CBD company on Tuesday, alleging that the business made several unsanctioned claims about the therapeutic benefits of their products.
The federal agencies accused Rooted Apothecary of unlawfully asserting that their cannabidiol products could treat symptoms of conditions such as ADHD, Parkinson’s disease, ear aches, ADHD and autism. Those claims appeared on the company’s website and social media accounts, they said.
Certain products appeared to be marketed as dietary supplements, which FDA currently prohibits as it works to develop an alternative regulatory scheme for CBD.
“Cannabis and cannabis-derived compounds are subject to the same laws and requirements as FDA-regulated products that contain any other substance,” Acting FDA Commissioner Ned Sharpless said in a press release. “We are working to protect Americans from companies marketing products with unsubstantiated claims that they prevent, diagnose, treat, or cure a number of diseases or conditions.”
FDA and FTC have issued a joint warning letter to a company marketing unapproved cannabidiol products with unsubstantiated claims to treat teething and ear pain in infants, autism, ADHD, Parkinson’s and Alzheimer’s disease, among other conditions/diseases. https://t.co/tsn4SBiGzH pic.twitter.com/sG3wyURMDS
— Dr. Ned Sharpless (@FDACommissioner) October 22, 2019
We’ve sent numerous warning letters that focus on matters of significant public health concern to CBD companies, and these actions should send a message to the broader market about complying with FDA requirements.
— Dr. Ned Sharpless (@FDACommissioner) October 22, 2019
“We’ve sent numerous warning letters that focus on matters of significant public health concern to CBD companies, and these actions should send a message to the broader market about complying with FDA requirements,” he said. “As we examine potential regulatory pathways for the lawful marketing of cannabis products, protecting and promoting public health through sound, science-based decision-making remains our top priority.”
FTC’s complaint with the company is that it violated a law that requires businesses that advertise medical claims about their products to have “competent and reliable scientific evidence” to back them up, which could include human clinical trials. Making or exaggerating such claims through “a product name, website name, metatags, or other means” without proper evidence is also prohibited.
FTC and @US_FDA warn Florida company marketing CBD products about claims related to treating autism, ADHD, Parkinson’s, Alzheimer’s, and other medical conditions: https://t.co/cAbxPPcxk8 pic.twitter.com/GdlttyBgxv
— FTC (@FTC) October 22, 2019
Rooted Apothecary must respond to the agencies within 15 working days to explain what steps it’s taking to resolve the issues. If the company fails to do so, it is subject to legal action, including the possible seizure of its products or an injunction. It may also have to compensate customers.
FDA emphasized that CBD products—other than the prescription medication Epidiolex, for the treatment of intractable epilepsy—are not currently allowed. But it also reiterated that the agency is in the process of developing rules that could allow for the lawful marketing of the compound.
In April, FDA sent warning letters to three other CBD companies that it said was making unauthorized claims about the medical benefits of their products. FTC also submitted warning letters to three separate CBD companies for allegedly advertising misleading statements about their products last month.
These letters are examples of the agency’s use of enforcement discretion. Former FDA Commissioner Scott Gottlieb, who recently suggested that the federal government should be involved in regulating state marijuana programs, clarified in March that the agency is only going after companies that make especially misleading claims about their products.
Senate Majority Leader Mitch McConnell (R-KY), who championed a provision of the 2018 Farm Bill federally legalizing hemp and its derivatives, has urged FDA to clear a path for the lawful marketing of CBD products by using enforcement discretion while it develops an interim final rule. A bipartisan group of lawmakers made a similar request in a letter sent to the agency last month.
“The FDA is working quickly to further clarify our regulatory approach for products containing cannabis and cannabis-derived compounds like CBD while using all available resources to monitor the marketplace and protect public health by taking action as needed against companies,” FDA Principal Deputy Commissioner Amy Abernethy said.
FDA’s working quickly to further clarify our regulatory approach for products with cannabis/cannabis-derivatives like CBD while using all available resources to monitor the marketplace & protect public health by taking action as needed against companies. https://t.co/HB9IhG2qud
— Dr. Amy Abernethy (@DrAbernethyFDA) October 22, 2019
We are committed to advancing our regulation of these products through an approach that, in line with our mission, prioritizes public health, fosters innovation and promotes consumer confidence. We plan to provide an update on our progress in this area in the near future.
— Dr. Amy Abernethy (@DrAbernethyFDA) October 22, 2019
“We recognize that there is significant public interest in cannabis and cannabis-derived compounds; however, we must work together to fill in the knowledge gaps about the science, safety and quality of many of these products,” she said. “We are committed to advancing our regulation of these products through an approach that, in line with our mission, prioritizes public health, fosters innovation and promotes consumer confidence.”
Photo courtesy of Kimzy Nanney.
GOP Senator Links Medical Marijuana Claims To Tobacco Industry Advertisements
Sen. John Cornyn (R-TX) said on Tuesday that claims about the therapeutic potential of marijuana remind him of decades-old tobacco industry advertisements asserting that the product had medical benefits.
In a speech on the Senate floor, Cornyn discussed a hearing that the International Narcotics Control Caucus, which he co-chairs, will hold on Wednesday to explore the public health impacts of cannabis. He said it was especially important to hear from experts about the subject as more states legalize marijuana and members of Congress, as well as Democratic presidential candidates, push to end federal prohibition.
Senate Hearing To Focus On Marijuana And Health This Week – https://t.co/aPZczm3X75
— Senator John Cornyn (@JohnCornyn) October 21, 2019
The senator made clear he’s skeptical about marijuana’s health benefits.
“There’s no shortage of people who claim that marijuana has endless health benefits and can help patients struggling from everything from epilepsy to anxiety to cancer treatments,” he said. “This reminds me of some of the advertising we saw from the tobacco industry years ago where they actually claimed public health benefits from smoking tobacco, which we know as a matter of fact were false and that tobacco contains nicotine, an addictive drug, and is implicated with cancers of different kinds.”
“We’re hearing a lot of the same happy talk with regard to marijuana and none of the facts that we need to understand about the public health impact of marijuana use,” he said.
While Cornyn recognized there’s significant support for cannabis reform, he said that ” for the number of voices in support of legalization, there are even more unanswered questions about both the short- and long-term public health effects.”
He expressed concern about increased levels of THC concentration in cannabis products and stated that it’s “true that for some people that marijuana can indeed be addictive.”
“There’s simply a lack of scientific evidence to determine the link between marijuana and various health risks, and that’s something I would think Congress and the American people would want to know before we proceed further down this path,” Cornyn said. “We don’t know enough about how this could impair cognitive function or capacity or increase the risk of mental illness or perhaps serve as a gateway for other drugs that are even more damaging to the health of a young person.”
The senator made similar remarks during a conversation with a former White House drug czar in August. He said it was important to address the public health impacts of cannabis before moving forward with legislation that would protect banks that service marijuana businesses from being penalized by federal regulators.
“With increasing use and a growing number of states giving the green light for marijuana use, we need better answers,” he said.
The surgeon general and the director of the National Institute on Drug Abuse, along with several academics, are scheduled to testify at Wednesday’s hearing.
Photo courtesy of C-SPAN.
Michael J. Fox Parkinson’s Foundation Urges Congress To Pass Three Marijuana Research Bills
A leading advocacy group that’s dedicated to finding treatment options for Parkinson’s disease is backing three pieces of marijuana research legislation in Congress.
The Michael J. Fox Foundation (MJFF)—named after the actor, who has Parkinson’s and established the nonprofit—said last week that lifting barriers to cannabis research, including rescheduling the plant under the Controlled Substances Act (CSA), is necessary to promote studies verifying marijuana’s potential therapeutic benefit for conditions such as Parkinson’s patients.
“The MJFF supports increased access to cannabis for medical research. Congress has begun to recognize this need, and there are several bills in the U.S. House and Senate designed to remove barriers that impede safe and legal access to cannabis by medical researchers,” the foundation said on its website. “The MJFF public policy team is tracking these bills and working to educate members of Congress and their staff on their importance to the Parkinson’s community.”
MJFF said it’s in favor of three marijuana bills, which would accomplish the following:
—Require the Justice Department to approve additional manufacturers for research-grade cannabis.
—Protect research institutions that conduct studies on marijuana.
—Authorize the U.S. Department of Veterans Affairs (VA) to inform patients about opportunities to participate in federally authorized cannabis studies.
—Require VA to conduct studies into the therapeutic potential of marijuana in the treatment of various conditions that commonly afflict veterans such as chronic pain and post-traumatic stress disorder.
—Reschedule marijuana from Schedule I to Schedule III under the CSA.
—Free up universities to conduct studies on cannabis by removing certain regulatory requirements.
In a letter to the Senate sponsor of that last piece of legislation, Sen. Dick Durbin (D-IL), in June, the foundation stated that marijuana’s current classification under federal law and the inadequate quality of cannabis grown at the only federally authorized manufacturing facility has meant that “researchers do not have the proper materials to conduct the necessary research.”
The foundation noted that it has submitted comments to the Food and Drug Administration arguing in favor of rescheduling in 2018 and 2019. It also applauded the Drug Enforcement Administration for announcing that it would take steps to approve additional federal cannabis farms for research.
“Current policies hinder comprehensive medical research on cannabis, making it difficult to generate the evidence needed for clear recommendations,” Andrew Koemeter-Cox, MJFF’s associate director of research programs, said. “This is especially problematic when some products may be unsafe for human use and have the potential for adverse interactions with other medications.”
Ted Thompson, the nonprofit’s senior vice president of public policy, said that removing barriers to research “is one way in which Congress can help scientific researchers determine what the benefits of medical cannabis might be for Parkinson’s disease.”
“Our role on the public policy team is to work with Congress and the administration to ensure there is access and funding for research and care initiatives that can benefit people living with Parkinson’s and, right now, that includes access to medical cannabis for research,” he said.
Photo courtesy of Brian Shamblen.